Our bodies are extremely efficient at storing fat from food into our fat tissue. In a new study, researchers from the University of Copenhagen have managed to completely block the development of obesity.
The researchers deleted an enzyme and made it impossible for mice to increase their amount of fat tissue, despite the mice eating an extremely fatty diet. They are hoping the findings will open new avenues for better treatment of obesity.
But today, where many of us have constant access to high calorie foods, our body’s impressive ability to convert food into fat has, ironically, become problematic. Consequently, the number of overweight people worldwide is skyrocketing, leading to large health consequences for both the individual and society.
However, as part of a new study, researchers at the University of Copenhagen have now managed to inhibit the body’s ability to store fat. They genetically delete the enzyme NAMPT in fat tissue of mice, and this renders the animals completely resistant to becoming overweight or obese, even on a very fatty diet.
‘We gave the mice a diet that more or less corresponds to continuously eating burgers and pizza. Still, it was impossible for them to expand their fat tissue. Our ultimate goal is that by understanding these fundamental underpinnings of how we become obese, we can apply our finding to the development of novel treatment strategies for metabolic disease,’ says Karen Nørgaard Nielsen, first author on the publication and a Ph.D. student at the Novo Nordisk Foundation Center for Basic Metabolic Research.
High-Fat Food, Same Weight
The findings are in line with results obtained from humans. Several studies have shown that the presence of large amounts of the enzyme NAMPT in blood and in stomach fat tissue is significantly connected with being overweight or obese. However, this study provides the first evidence that NAMPT is absolutely required to become overweight or obese and that lack of NAMPT in fat tissue fully protects against obesity.
In the University of Copenhagen study, the researchers compared how normal mice and mice lacking NAMPT in fat tissue gained weight when given either high-fat food or a healthier, lower-fat diet. When on the healthy diet, there was no difference in body weight or the amount of fat between the normal mice and the mice lacking NAMPT.
However, when the mice were given high-fat food, the control mice became very obese, yet the mice lacking NAMPT gained no more weight from high-fat food than when they were on the healthier diet. In addition, the mice lacking NAMPT maintained better control of blood glucose than normal mice when eating high-fat food.
Contradicts the General View
The result challenges the general view of NAMPT, which is largely seen as an enzyme that should be boosted for therapeutic purposes.
‘NAMPT appears to increase the metabolic functionality of almost every tissue in the body in which it has been studied. For example, there are indications that the liver and skeletal muscle may benefit from increased NAMPT activity. We similarly find that NAMPT is critical for fat tissue function. Unfortunately, that function is efficiently storing fat. NAMPT in fat tissue was likely once an extraordinary benefit to our ancestors but in today’s society full of high-fat, calorically-dense foods, it may now pose a liability’, says Associate Professor Zachary Gerhart-Hines from the Novo Nordisk Foundation Center for Basic Metabolic Research and corresponding author on the study.
He does not necessarily believe that generally decreasing NAMPT is a viable treatment strategy in humans. There would be too great a risk for potentially harmful consequences in other tissues of the body.
However, he suggests that this study may pave the way for more research into how NAMPT is linked to the storage of fat from the food we eat. By learning biologically how we become obese in the first place, he hopes that it will eventually be possible to target one of the underlying mechanisms in humans to treat obesity and metabolic disease.
The Latest on: Obesity
via Google News
The Latest on: Obesity
- Inflammation triggered by obesity may cause brain damageon November 30, 2019 at 8:30 am
A study scheduled to be presented next week has found evidence of brain damage linked to obesity in teenagers. The damage impacts the parts of the brain responsible for cognitive functions, as well as ...
- Anti-obesity Drugs Market Future Prospects 2025on November 30, 2019 at 7:19 am
Nov 30, 2019 (HTF Market Intelligence via COMTEX) -- HTF MI newly added the Global (United States, European Union and China) Anti-obesity Drugs Market Study that gives meticulous investigation of ...
- Obesity is an epidemic — Why haven't we responded accordingly?on November 30, 2019 at 6:00 am
Deaths attributable to opioid overdoses accounted for 400,000 deaths in the U.S. between 1999-2017. Obesity, a chronic disease, is held to a different standard, despite meeting most of the criteria ...
- Turning the tables on obesity: young people, IT and social movementson November 29, 2019 at 7:32 am
Despite the rising incidence of childhood obesity, international data from Eurostat show that the prevalence of obesity among those aged 15–19 years remains under 5%, which offers an important ...
- Childhood obesity rising in West Virginiaon November 28, 2019 at 8:00 pm
HUNTINGTON — Despite rates declining nationally, the obesity rate among children ages 2 to 4 participating in the Special Supplemental Nutrition Program for Women, Infants and Children (WIC) in West ...
- Obesity 'triggers inflammation that damages the brain’on November 28, 2019 at 3:44 am
Obesity may trigger inflammation that damages the brain, research suggests. Scientists from the University of São Paulo compared the brain scans of 59 obese teenagers and 61 adolescents of a healthy ...
- Obesity: a neuroimmunometabolic perspectiveon November 27, 2019 at 10:11 am
This interplay is particularly prevalent within adipose tissue, where immune cells and the sympathetic nervous system (SNS) have an important role in metabolic homeostasis and pathology, namely in ...
- Can obesity limit antiarrhythmic drug effectiveness?on November 27, 2019 at 8:03 am
Atrial fibrillation, also known as AFib, is the most common type of irregular heartbeat, and it is associated with increased mortality. While researchers have identified a causal link between obesity ...
- Scientists Look At Hibernating Bears’ DNA To Help Treat Obesityon November 27, 2019 at 4:00 am
Geneticists might have made a breakthrough discovery in terms of treating obesity problems. They found out that the genes of bears that hibernate have a semblance to genes of human beings who are ...
via Bing News